17AAG Treatment Accelerates Doxorubicin Induced Cellular Senescence: Hsp90 Interferes with Enforced Senescence of Tumor Cells
Hsp90 chaperone has been identified as an attractive pharmacological target to combat cancer. However, some metastatic tumors either fail to respond to Hsp90 inhibition or show recovery necessitating irreversible therapeutic strategies. In response to this enforced senescence has been proposed as an...
Saved in:
Main Authors: | Upasana Sarangi (Author), Khande Rao Paithankar (Author), Jonnala Ujwal Kumar (Author), Vaidyanathan Subramaniam (Author), Amere Subbarao Sreedhar (Author) |
---|---|
Format: | Book |
Published: |
AboutScience Srl,
2012-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
17AAG Treatment Accelerates Doxorubicin Induced Cellular Senescence: Hsp90 Interferes with Enforced Senescence of Tumor Cells
by: Jonnala Ujwal Kumar, et al.
Published: (2012) -
by: Upasana Sarangi, et al.
Published: (2012) -
Repercussion of Mitochondria Deformity Induced by Anti-Hsp90 Drug 17AAG in Human Tumor Cells
by: Chaturvedi Vishal, et al.
Published: (2011) -
Repercussion of Mitochondria Deformity Induced by Anti-Hsp90 Drug 17AAG in Human Tumor Cells
by: Chaturvedi Vishal, et al.
Published: (2011) -
Hsp60 Chaperonin Acts as Barrier to Pharmacologically Induced Oxidative Stress Mediated Apoptosis in Tumor Cells with Differential Stress Response
by: Upasana Sarangi, et al.
Published: (2013)